


Ribonexus appoints Steven Powell as CEO

Univercells raises € 44 million in first close of its Series D

Tridek-One closes a €16 million financing round to develop first-in-class imune checkpoint agonists

SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases
